Oncocross
Manufacturing · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
16f Gongdeok Bldg. Saechange-ro 11, Mapo...Phone Number
+82 28679967Website
www.oncocross.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Oncocross
Founded in 2015 and based out of Seoul, South Korea, Oncocross is an AI-driven biopharmaceutical company.Explore more
Oncocross Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oncocross your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Oncocross has recently received funding, and reach out quickly before it becomes old news!
Oncocross, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Oncocross recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Oncocross is spiking on competitors!
Click to see if Oncocross had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Oncocross
Funding: Get notified immidiatlly once Oncocross has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Oncocross launches new products
Recommended Actions
Find VP level buyers at Oncocross
Find 2 more new buyers
Company Profile Activity
Activity Insights
Oncocross is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Oncocross is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oncocross.
Oncocross Tech Stack
A closer look at the technologies used by Oncocross
See more technologies
Oncocross News & Media
Oncocross Completes Phase I Global Clinical Trial of OC514, Treatment for Sarcopenia
SEOUL, South Korea--(BUSINESS WIRE)-- #AIbiotech--Oncocross, an AI drug discovery and development biotech, completed the phase 1 global clinical trial of OC514, a treatment for rare muscular diseases.Oncocross Begins Clinical Trial for AI-Developed Drug for Sarcopenia
SEOUL, South Korea--(BUSINESS WIRE)-- #AIBiotech--Oncocross, an AI-based drug development biotech, begins a phase I global clinical trial for OC514 targeting muscular diseases including sarcopenia.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Oncocross
Sign Up For FreeTo access detailed company insights
Founded in 2015 and based out of Seoul, South Korea, Oncocross is an AI-driven biopharmaceutical company.... Read More
